Enhance MD review

Enhance MD organizes its weight-management program around laboratory testing and a video consultation. The FAQ describes baseline blood work at Quest Diagnostics before the initial visit, with ongoing metabolic monitoring every six months. That is a concrete service feature to compare with programs that leave testing to another clinician. It does not establish that the treatment will work for a particular patient or that another appropriate care model is inadequate. The company identifies itself as an administrative platform, with care delivered through medical groups including Enhance Wellness PC and iThriveMD PC; the terms additionally name EnhanceMD CA PC. A payment starts onboarding; it does not guarantee a prescription or dispensing.

The pharmacy disclosures need reconciliation. The FAQ lists Tru Meds Rx, Strive Pharmacy and Pharmacy Hub. The terms separately list Rite-Away Pharmacy, Vios Compounding Pharmacy and TruMedsRx, with addresses. These are different partner lists, not proof that all are used for every treatment or that an order will go to a particular location. Enhance MD remains outside the recommendations pending a clear dispensing assignment. Ask for the exact facility, address and state authorization before ordering, then verify that facility through its regulator. A brand name shared across several pharmacy locations does not identify the license for the location handling your medication.

The short product offers expressly bill every four weeks. The monthly comparison figures here are $270.49 for semaglutide, $357.40 for tirzepatide, $216.18 for NAD+ injections and $107.54 for the wafer. These are 365-day annualized comparisons, not the amount of an individual charge. A fixed twenty-eight-day renewal moves through calendar months. Longer offers bill every twelve, twenty-four or forty-eight weeks; a plan called twelve months therefore needs its actual duration checked. Confirm the full prepaid charge and later renewal rather than multiplying a headline without reading the schedule.

The GLP-1 menu describes one price across doses within a selected plan. Microdose tirzepatide instead begins with a twelve-week commitment, and the Elite product markets semaglutide together with tirzepatide. A combination product should not be treated as an approved version of either medicine or assumed to improve outcomes. Approved GLP-1 labeling limits coadministration with other GLP-1 receptor agonists; discuss why a combination is proposed and what evidence supports it. The NAD+ page also makes rapid-energy and longevity claims. The presence of medical oversight or a choice between injection and wafer does not prove those benefits or establish that the routes perform equivalently.

The FAQ says the standard program includes lab work, virtual visits, medication through partner pharmacies and shipping. Baseline testing includes CMP, lipids, TSH and A1c, with fasting recommended in the onboarding material. Confirm which requirements apply to the exact NAD+ or weight-management product rather than assuming every pathway is identical. The FAQ describes a 40-state-plus-DC launch list despite a broader licensing claim, so state access needs checking. It also says FSA and HSA cards are not accepted. If using an outside pharmacy, medication is billed separately at that pharmacy’s prices rather than automatically included in the platform bundle.

Cancellation and delivery deserve separate questions. The terms require cancellation before the next billing cycle and place detailed subscription conditions at checkout; the FAQ permits pausing or canceling through support. It promises a full initial-payment refund if onboarding finds the patient ineligible, not an unconditional refund at any later stage. The FAQ also asserts that its medication withstands unrefrigerated shipping and extreme temperatures. That broad assurance should not override FDA’s warning against using an injectable GLP-1 that arrives warm or insufficiently refrigerated. Ask the dispensing pharmacist to assess the actual shipment and product label before use. The reviewed material does not establish a universal two-day delivery guarantee.